The role of miRNA and lncRNA in gastric cancer

Ning-Bo Hao; Ya-Fei He; Xiao-Qin Li; Kai Wang; Rui-Ling Wang

doi:10.18632/oncotarget.19197

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

The role of miRNA and lncRNA in gastric cancer

Ning-Bo Hao, Ya-Fei He, Xiao-Qin Li, Kai Wang and Rui-Ling Wang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:81572-81582. https://doi.org/10.18632/oncotarget.19197

Metrics: PDF 4676 views | HTML 6183 views | ?

Abstract

Ning-Bo Hao1,*, Ya-Fei He2,*, Xiao-Qin Li3, Kai Wang4 and Rui-Ling Wang1

1Department of Gastroenterology, General Hospital of the PLA Rocket Force, Beijing, China

2Intensive Medical Center, 302 Hospital of PLA, Beijing, China

3Department of Ophthalmology, General Hospital of the PLA Rocket Force, Beijing, China

4New Era Stoke Care and Research Institute, General Hospital of the PLA Rocket Force, Beijing, China

*These authors contributed equally to this work

Correspondence to:

Rui-Ling Wang, email: [email protected]

Keywords: gastric cancer, miRNA, lncRNA

Received: April 03, 2017 Accepted: June 20, 2017 Published: July 12, 2017

ABSTRACT

Gastric cancer is one of the most common cancers and has the highest mortality rate worldwide. It is worthwhile to explore the mechanism of gastric cancer progression. An increasing number of studies have found that non-coding RNAs including miRNA and lncRNA play important roles in gastric cancer progression. This review summarized the role of ectopic miRNA in gastric cancer proliferation, growth, migration, invasion and apoptosis. Meantime, aberrantly expressed miRNA also received a great deal of attention as potential biomarker for gastric cancer diagnosis and therapy. Over the last decade, lncRNA was considered to regulate gastric cancer progression at the transcript and post-transcript level. At the transcript level, lncRNA induced gastric cancer progression by changing chromatin modification and mRNA stabilization to regulate mRNA and miRNA expression. Furthermore, lncRNA regulated gastric cancer progression by completely combining with miRNA to produce ceRNA or promote protein stabilization at the post-transcript level. Greater attention of miRNA and lncRNA in gastric cancer can provide new insight of mechanism of cancer development and may be acted as a new anticancer target.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19197

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

The role of miRNA and lncRNA in gastric cancer

Abstract